PharmaCyte Biotech PMCB Q1 2026 Earnings Revenue NA Matching Views MDxHealth SA MDXH Q1 2026 Results Fall Short EPS 017 Revenue NA Teva Pharmaceutical TEVA Reports Q1 Beat Unveils Amylyx Deal Plans SPTSX Banking Sector Trends Could Shape TorontoDominions Growth Trajectory PCAPW Plunges 17 as Warrants Test Support at 028 Churchill Downs CHDN Faces Headwinds Stock Dips 316 Amid Volume Concerns Social Commerce Partners SCPQ Consolidates Near Key Support Potential Breakout or Breakdown Ahead Editas Medicine Gains 337 as Gene Editing Biotech Tests Key Resistance at 29